Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
September 10, 2022
Identification and characterization of pleiotropic and epistatic QDRL conferring partial resistance to Pythium irregulare and P. sylvaticum in soybean
Feng Lin, Wenlong Li, Austin G McCoy, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 18, 2024
Skin α-Synuclein Seeding Activity in Patients with Type 1 Gaucher Disease
Mary Kate LoPiccolo, Zerui Wang, Gadi Maayan Eshed, et al.
Digestive Diseases and Sciences
|
February 22, 2023
Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C
Herbert L Bonkovsky, Sean P Rudnick, Christopher D Ma, et al.
Bioinformatics (Oxford, England)
|
August 14, 2021
PyJAMAS: open-source, multimodal segmentation and analysis of microscopy images
Rodrigo Fernandez-Gonzalez, Negar Balaghi, Kelly Wang, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
May 9, 2022
Racial and Ethnic Disparities Among Women Undergoing a Trial of Labor After Cesarean Delivery: Performance of the VBAC Calculator with and without Patients' Race/Ethnicity
Ayisha Buckley, Stephanie Sestito, Tonia Ogundipe, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 26, 2023
Human pharmacokinetics prediction with an <i>in vitro</i>-<i>in vivo</i> correction factor approach and <i>in vitro</i> drug-drug interaction profile of bictegravir, a potent integrase-strand transfer inhibitor component in approved biktarvy<sup>®</sup> for the treatment of HIV-1 infection
Raju Subramanian, Jianhong Wang, Bernard Murray, et al.
Antimicrobial Agents and Chemotherapy
|
January 20, 2011
In vitro characterization of GS-8374, a novel phosphonate-containing inhibitor of HIV-1 protease with a favorable resistance profile
Christian Callebaut, Kirsten Stray, Luong Tsai, et al.
Molecular Pharmaceutics
|
November 2, 2023
Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent
Raju Subramanian, Jennifer Tang, Jim Zheng, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 8, 2024
Lenacapavir Exhibits Atropisomerism-Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance Pathway
Jim Zheng, Bing Lu, Gavin Carr, et al.
Journal of Medicinal Chemistry
|
August 17, 2016
Correction to Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection
John O Link, James G Taylor, Lianhong Xu, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
September 10, 2022
Identification and characterization of pleiotropic and epistatic QDRL conferring partial resistance to Pythium irregulare and P. sylvaticum in soybean
Feng Lin, Wenlong Li, Austin G McCoy, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 18, 2024
Skin α-Synuclein Seeding Activity in Patients with Type 1 Gaucher Disease
Mary Kate LoPiccolo, Zerui Wang, Gadi Maayan Eshed, et al.
Digestive Diseases and Sciences
|
February 22, 2023
Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C
Herbert L Bonkovsky, Sean P Rudnick, Christopher D Ma, et al.
Bioinformatics (Oxford, England)
|
August 14, 2021
PyJAMAS: open-source, multimodal segmentation and analysis of microscopy images
Rodrigo Fernandez-Gonzalez, Negar Balaghi, Kelly Wang, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
May 9, 2022
Racial and Ethnic Disparities Among Women Undergoing a Trial of Labor After Cesarean Delivery: Performance of the VBAC Calculator with and without Patients' Race/Ethnicity
Ayisha Buckley, Stephanie Sestito, Tonia Ogundipe, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 26, 2023
Human pharmacokinetics prediction with an <i>in vitro</i>-<i>in vivo</i> correction factor approach and <i>in vitro</i> drug-drug interaction profile of bictegravir, a potent integrase-strand transfer inhibitor component in approved biktarvy<sup>®</sup> for the treatment of HIV-1 infection
Raju Subramanian, Jianhong Wang, Bernard Murray, et al.
Antimicrobial Agents and Chemotherapy
|
January 20, 2011
In vitro characterization of GS-8374, a novel phosphonate-containing inhibitor of HIV-1 protease with a favorable resistance profile
Christian Callebaut, Kirsten Stray, Luong Tsai, et al.
Molecular Pharmaceutics
|
November 2, 2023
Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent
Raju Subramanian, Jennifer Tang, Jim Zheng, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 8, 2024
Lenacapavir Exhibits Atropisomerism-Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance Pathway
Jim Zheng, Bing Lu, Gavin Carr, et al.
Journal of Medicinal Chemistry
|
August 17, 2016
Correction to Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection
John O Link, James G Taylor, Lianhong Xu, et al.
Page
of 5